page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Dimercaprol (British AntiLewisite, BAL in Oil)

Category:

  • Miscellaneous

Description:

  • Heavy metal antidote (arsenic, gold, mercury, lead)

Indications:

  • Treatment of arsenic, mercury, and mercury poisoning

  • Acute lead poisoning (in conjuction with  cascium edetate disodium)

Contraindications:

  • Hepatic insufficiency (except postarsenic jaundice

  • Iron, cadmium, or selenium poisoning; severe renal disease

Precautions:

  • Pregnancy category D; use only in life threatening poisoning

  • Acute renal insufficiency, G-6-PD deficiency, acidic urine, hypertension

Adverse Reactions (Side Effects):

  • CNS: anxiety, headache, sweating

  • CV: rise in blood pressure; tachycardia

  • EENT: burning sensation in the lips, mouth and throat, conjunctivitis, lacrimation, blepharal spasm, feeling of constriction in the throat, rhinorrhea

  • GI: abdominal pain, nausea, salivation, vomiting

  • GU: burning sensation in the penis

Dosage:

Administer DEEP IM ONLY . Adult and child:

  • Mild arsenic and gold poisoning: 

    • IM 2.5 mg/kg/dose every 6 hours for 2 days

    • then every 12 hours on 3rd day

    • then daily for 10 days thereafter

  • Severe arsenic and gold poisoning: 

    • IM 3mg/kg/dose every 4 hours for 2 days

    • then every 6 hours on 3rd day

    • then every 12 hours thereafter for 10 days

  • Mercury poisoning: 

    • IM 5 mg/kg initially followed by 2.5 mg/kg/dose once to twice daily for 10 days

  • Lead poisoning: 

    • IM 4 mg/kg alone for first dose

    • then 3-4 mg/kg/dose with calcium edetate disodium administered at a separate site every 4 hours for 5-7 days

 

 

 


The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site